Scholars Central

Conference abstractPublished 14 Sep 2015

Green by design for process evolution: Asymmetric syntheses of vibegron

Authors: Feng Xu

Merck Research Laboratories, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Vibegron is a potent and selective beta-3 adrenergic receptor agonist and a drug candidate currently in clinical trials for the treatment of overactive bladder. In addition to the initial discovery chemistry route, two generations of asymmetric syntheses of vibegron are described in this presentation. The evolution of the two asymmetric routes suitable for the large scale preparation of vibegron is driven by the desire to develop a greener chemistry through the design of efficient chemical transformations / bond connections as well as process optimization. In comparison with the 1st generation route, the 2nd generation synthesis also reduces the manufacturing cost significantly.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectEnvironmental & Earth Sciences
  • BylineArticles whose byline prints “Feng Xu”